Equities

Blancco Technology Group PLC

Blancco Technology Group PLC

Actions
  • Price (GBX)241.00
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+27.01%
  • Beta0.3880
Data delayed at least 15 minutes, as of Jan 21 2021 11:13 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Blancco Technology Group Plc, formerly Regenersis Plc, is a provider of mobile device diagnostics and secure data erasure solutions. The Company's segments include Erasure and Diagnostics. The Erasure segment focuses on development and delivery of solutions, and includes Blancco, which provides erasure software; SafeIT, which is engaged in cloud and networked data erasure business, and Tabernus, which is engaged in providing software erasure products. The Diagnostic segment includes Xcaliber Technologies, a smartphone diagnostics software business. Its secure data erasure solutions include Blancco Management Console, Blancco Cloud, Blancco File, Blancco 5, Blancco Mobile Solutions, Enterprise Erase E800, Enterprise Erase E2400, Enterprise Erase Mobile and Ontrack Eraser Degausser. Its mobile diagnostics solutions include fault diagnostics, repair and program enablement. It serves manufacturers, financial institutions, healthcare providers and government organizations across the world.

  • Revenue in GBP (TTM)33.38m
  • Net income in GBP27.00k
  • Incorporated2004
  • Employees312.00
  • Location
    Blancco Technology Group PLCUnit 6B, Vantage Park, Washingley RoadHUNTINGDON PE29 6SRUnited KingdomGBR
  • Phone+44 207 264 4405
  • Fax+44 203 657 7019
  • Websitehttps://www.blancco.com/
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.